Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
5.14
+0.13 (2.59%)
Nov 21, 2024, 11:17 AM EST - Market open
Elicio Therapeutics Employees
Elicio Therapeutics had 32 employees as of December 31, 2023. The number of employees increased by 9 or 39.13% compared to the previous year.
Employees
32
Change (1Y)
9
Growth (1Y)
39.13%
Revenue / Employee
n/a
Profits / Employee
-$1,463,844
Market Cap
55.31M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 32 | 9 | 39.13% |
| Dec 31, 2022 | 23 | -1 | -4.17% |
| Dec 31, 2021 | 24 | 2 | 9.09% |
| Dec 31, 2020 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| 111, Inc. | 1,520 |
| Singular Genomics Systems | 255 |
| Enzo Biochem | 136 |
| Vicarious Surgical | 131 |
| DBV Technologies | 105 |
| Aadi Bioscience | 89 |
| Owlet | 76 |
| Shattuck Labs | 75 |
ELTX News
- 7 days ago - Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 13 days ago - Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer (“SITC”) 2024 Annual Meeting - GlobeNewsWire
- 21 days ago - Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation Summit - GlobeNewsWire
- 5 weeks ago - Elicio Therapeutics Reports Inducement Grants - GlobeNewsWire
- 2 months ago - Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted, mKRAS-Specific Amphiphile Vaccines - GlobeNewsWire
- 3 months ago - Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 5 months ago - Elicio Therapeutics Announces Proposed Public Offering - GlobeNewsWire